
中东呼吸综合征冠状病毒及其疫苗和特异性药物的研发
Middle East respiratory syndrome coronavirus and development of vaccines and specific drugs for its control
中东呼吸综合征冠状病毒(MERS-CoV)是引起MERS的病原。本文就MERS-CoV的分类、特性、决定宿主特异性的分子结构及其疫苗研究状况和特异性药物研究进展等方面进行综述。
Middle East respiratory syndrome (MERS) is a viral infection caused by a novel coronavirus (MERS-CoV). In this review, we focus on the classification, molecular structure and the proteins related to tissue tropisms and host range of MERS-CoV. The efforts on development of drugs and vaccines for the control of MERS-CoV are also discussed.
中东呼吸综合征冠状病毒 / 中东呼吸综合征 / 疫苗 / 抗中东呼吸综合征冠状病毒中和抗体
Middle East respiratory syndrome coronavirus / Middle East respiratory syndrome / Vaccine / Anti-Middle East respiratory syndrome coronavirus neutralization antibody
国家自然科学基金(81173098)
/
〈 |
|
〉 |